SARS-CoV-2-induced remission of Hodgkin lymphoma

Br J Haematol. 2021 Feb;192(3):415. doi: 10.1111/bjh.17116. Epub 2021 Jan 2.
No abstract available

Publication types

  • Case Reports
  • Lecture

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / diagnosis*
  • COVID-19 / immunology
  • COVID-19 / therapy
  • Clinical Decision-Making
  • Disease Management
  • Hodgkin Disease / complications*
  • Hodgkin Disease / diagnosis*
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / immunology
  • Humans
  • Male
  • Middle Aged
  • Patient Outcome Assessment
  • SARS-CoV-2*